Axim® Biotechnologies granted a “patent” for suppository formulations comprising of cannabinoids
AXIM® Biotechnologies, Inc., a world leader in cannabinoid research and product development, announced that the United States Patent and Trademark Office (USPTO) has issued the company a new Notice of Allowance for a patent (Application No. 16/122,079) on a suppository composition comprising cannabinoids.
Can CBD Help with Chronic Illness Symptoms?
Chronic illness is defined as a disease that lasts longer than 3 months. Many people suffer from multiple chronic diseases at once. Almost a third of the population is now living with multiple chronic conditions.
Our CBD Studies & Research Area
For the past 5 months, we have been putting together a knowledge base of known ailments that CBD can help treat. Here you can view current and past CBD studies & research. Our knowledge base is searchable. You can search for an ailment like autism and bring up studies and research on it. As full […]
Hebrew University set up Lab to study Cannabinoid-based treatments
At the Hebrew University of Jerusalem, a $2.3 million investment has allowed Lumir Lab, a cannabinoid research lab, to set up on campus to study cannabinoid-based treatments. The investment came from Asana Bio Group Ltd., an Israeli company with a specialty in medical cannabis ventures. The lab will provide analyses, solutions, and clinical validation to companies […]